If you think MicroStrategy’s business model is wild, wait until you see its tax issues. After years of raising money through ...
Mr. Bruni is a contributing Opinion writer. Ms. McLean is a contributing editor at Vanity Fair and an author of “The Smartest ...
January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...
The new Enron has been dismissed by many as a joke or a publicity stunt, but recent filings and a newly-revealed executive ...
The exposé led to the company’s CEO going to jail and to Anderson’s short-selling firm, Hindenburg Research, becoming one of ...
After four years as president, the Houston Texans are parting ways with Greg Grissom, who has been with the team since its inaugural season 25 years ago.
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
There’s a saying that opportunity follows policy. This is especially true in highly regulated industries where regulation ...
The disbanding of activist short seller Hindenburg Research last week made it clear: The business of uncovering fraud in public companies has become one of the riskiest, burdensome, and often loathed ...
Responsible private sector leadership, with a true connection between business success and societal stability, is the best ...
Despite accounting fraud rumors, Super Micro Computer's products are essential for AI, and a new auditor is fueling renewed ...